Detection of the XE subvariant of SARS-CoV-2: A perspective.
作者信息
Rahimi Farid, Talebi Bezmin Abadi Amin
机构信息
Research School of Biology, The Australian National University, Ngunnawal and Ngambri Country, Canberra, Australia.
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
出版信息
Int J Surg. 2022 May;101:106642. doi: 10.1016/j.ijsu.2022.106642. Epub 2022 Apr 28.
Abstract
摘要
相似文献
1
Detection of the XE subvariant of SARS-CoV-2: A perspective.
Int J Surg. 2022 May;101:106642. doi: 10.1016/j.ijsu.2022.106642. Epub 2022 Apr 28.
2
Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection.
J Infect. 2022 Aug;85(2):e37-e39. doi: 10.1016/j.jinf.2022.05.035. Epub 2022 Jun 1.
3
The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic.
Int J Surg. 2022 Mar;99:106261. doi: 10.1016/j.ijsu.2022.106261. Epub 2022 Feb 12.
4
Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes.
Signal Transduct Target Ther. 2022 Dec 25;7(1):395. doi: 10.1038/s41392-022-01256-9.
5
University-Associated SARS-CoV-2 Omicron BA.2 Infections, Maricopa County, Arizona, USA, 2022.
Emerg Infect Dis. 2022 Jul;28(7):1520-1522. doi: 10.3201/eid2807.220470. Epub 2022 Jun 2.
6
SARS-COV-2 Omicron subvariant BF.7 is again triggering the Covid fear: What we need to know and what we should do?
J Med Virol. 2023 Feb;95(2):e28551. doi: 10.1002/jmv.28551.
7
Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023.
Int J Surg. 2023 Apr 1;109(4):658-659. doi: 10.1097/JS9.0000000000000258.
8
Higher SARS-CoV-2 shedding in exhaled aerosol probably contributed to the enhanced transmissibility of Omicron BA.5 subvariant.
J Med Virol. 2023 Jan;95(1):e28365. doi: 10.1002/jmv.28365.
9
A commentary on 'Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023'.
Int J Surg. 2023 Oct 1;109(10):3197-3198. doi: 10.1097/JS9.0000000000000576.
10
SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread.
Signal Transduct Target Ther. 2023 Nov 30;8(1):439. doi: 10.1038/s41392-023-01712-0.
引用本文的文献
1
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2.
Front Microbiol. 2023 Jul 25;14:1228128. doi: 10.3389/fmicb.2023.1228128. eCollection 2023.
2
Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic.
Environ Health Insights. 2022 Oct 20;16:11786302221129396. doi: 10.1177/11786302221129396. eCollection 2022.
3
Emergence of novel omicron hybrid variants: BA(x), XE, XD, XF more than just alphabets.
Int J Surg. 2022 Aug;104:106727. doi: 10.1016/j.ijsu.2022.106727. Epub 2022 Jun 24.
本文引用的文献
1
Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants.
Aging Dis. 2022 Apr 1;13(2):402-422. doi: 10.14336/AD.2021.1210. eCollection 2022 Apr.
2
SARS-COV-2 Variants: Differences and Potential of Immune Evasion.
Front Cell Infect Microbiol. 2022 Jan 18;11:781429. doi: 10.3389/fcimb.2021.781429. eCollection 2021.
3
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
Lancet. 2021 Dec 11;398(10317):2126-2128. doi: 10.1016/S0140-6736(21)02758-6. Epub 2021 Dec 3.
4
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
Science. 2021 Dec 17;374(6574):eabl9551. doi: 10.1126/science.abl9551.
Zotero 插件